๐ Milestone achieved!
The NHS-wide clinical trial of AlcoChange DTx for alcohol-related liver disease has officially completed Last Patient, Last Visit.
๐ 324 participants &
๐ฅ 26 NHS hospitals
A huge thank you to all the staff, teams and participants. https://t.co/077nH7hZhW
This week is #AlcoholAwarenessWeek with a theme of 'Understanding #AlcoholHarm
Itโs a chance to think about drinking and understand alcohol harm and the centre-stage role that it plays in our lives and raise awareness among our friends and family.
@helloDryDays@CyberLiver@NHSuk
By 2030, liver disease is expected to become one of the top three health concerns in the UK, a challenge intensified by the shortfall in specialist care. On #WorldLiverDay we aim to address these challenges through our #DigitalMedicineDevice platform. @DHealthLDN thank you๐
It's time to shine the #DHLSpotlight! ๐
Every week, we shine a spotlight on one of our companies, founders, or #NHS fellows.
Today, to commemorate #WorldLiverDay, we are excited to feature current #DHLAccelerator company @CyberLiver.
Find out more:
https://t.co/RLzTiaf51y
1.5 billion people live with chronic liver disease, and 2 million lives are lost yearly.ย Early prevention can save many of these lives. We are are working on #DigitalMedicineDevices which could halt, reverse or manage liver disease. #WorldLiverDay#livertwitter
A very engaging and insightful session about alcohol consumption trends and harm since the pandemic
It's worrying and sad. ๐ช Digital interventions like @helloDryDays by AlcoChange are aiming to help reduce that harm and burden. #MACPconf#alcoholharm@rcgp@VictimOfMaths
Down in that there London today @rcgp to talk to a room full of GPs and addiction professionals at #MAPCconf about trends in alcohol consumption and harms since the pandemic. I have brought shiny new graphs.
๐ That's a wrap ๐What an incredible conference it's been! Lots of learning and connections ๐ซ #BASL2023#BASL#CyberLiver#LiverTwitter#BLNA#BLTG
If you've missed visiting us you can find all about us https://t.co/vPTzYGuviY
๐จ ๐ป๐๐ง๐๐ฃ๐ค๐๐ฅ๐ช ๐๐๐ ๐๐๐๐๐ฆ๐ค๐๐ ๐ ๐๐ ๐ก๐๐ฅ๐๐๐๐ฅ ๐๐๐ฃ๐ ๐๐ฃ๐ ๐ฆ๐ก ๐๐ ๐ฃ ๐๐๐ค๐๐ฆ๐ค๐ค๐๐ ๐ ๐๐๐ฉ๐ฅ. How can technology assist? Ask our experts to know more and how we are making a difference.
#BASL2023 ๐จ #BASL#DigitalMedicine#LiverDisease
๐Day 2 of #BASL2023 is underway! We're excited for today's discussions on Personalising Liver Care. Drop in for a quick demo to know how we're personalising digital therapies for patients with ArLD and Cirrhosis. See you at Durham Hall! #CyberLiver@CirrhoCare@alcochange#BASL
Pleasure to meet @DrADhanda at our booth and demonstrating CirrhoCare at #BASL2023#BASL. Great conversation and lots of questions and learning for us. ๐ก Looking forward to meeting you again.
@AnuBalajiRaja@CirrhoCare#LiverTwitter great start to another exciting day ahead ๐
Following the @CirrhoCare study, we demonstrate that fat mass could be an important digital nutritional biomarker in decompensated cirrhosis! https://t.co/OW1fi08ccQ.
Looking forward to validating these findings in the upcoming RCT! @rajmookerjee@CyberLiver#digitalhealth